logo

Alopecia Treatment (Hair Loss) Market Size (2024 - 2029)

The alopecia treatment market is anticipated to experience growth due to increasing demand driven by factors such as sedentary lifestyles, unhealthy diets, aging, and hormonal imbalances, which contribute to hair loss. The prevalence of androgenetic alopecia, particularly among men, further underscores the need for effective treatments. The approval and upcoming launch of novel drugs by regulatory bodies are expected to significantly influence the market size, as these innovations cater to the growing number of patients seeking solutions for hair loss.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Immune System Drugs Research Autoimmune Disorders Research Androgenetic Alopecia Industry Market Size

Market Size of Alopecia Treatment (Hair Loss) Industry

Alopecia Treatment (Hair Loss) Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 5.20 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Alopecia Treatment (Hair Loss) Market Major Players

*Disclaimer: Major Players sorted in no particular order

Alopecia Treatment (Hair Loss) Market Analysis

Alopecia is a term used to describe excessive hair damage under certain medical conditions or dietary issues. A sedentary lifestyle and unhealthy diets are leading to loss of hair among masses. Furthermore, aging and hormonal imbalance, increasing chronic diseases like arthritis, cancer, hypertension, depression also leads to hair loss, especially among the middle-aged population. According to the American Hair Loss Association, androgenetic alopecia accounts for over 95% of hair loss in men. Over 800 thousand patients are seeking some kind of treatment for hair loss worldwide.

In recent years, many novel drugs have been approved by the regulatory bodies for the treatment of alopecia and many drugs are in pipeline, which are expected to receive approval in the near future. Concert Pharmaceuticals Inc. received fast track designation from the United States Food and Drug Administration, (FDA) for its novel product for the treatment of moderate-to-severe alopecia areata in January 2018. The launches of such novel products in the market is expected to drive the global alopecia treatment market growth in the near future.

Alopecia Treatment (Hair Loss) Industry Segmentation

As per the scope of the report, alopecia treatment (Hair Loss) is the drugs that are indicated for the treatment of alopecia. The alopecia treatment (hair loss) drugs, like minoxidil, finasteride, and cyclosporine, which are indicated for the treatment of alopecia are covered. Alopecia also called hair-loss or baldness is a medical condition that refers to the loss of hair from the head or any part of the body.

By Disease Type
Androgenic Alopecia
Alopecia Areata
Ciatricial Alopecia
Traction Alopecia
Alopecia Totalis
By Gender
Male
Female
By Route of Administration
Oral
Topical
Injectable
By Distribution Channel
Hospitals
Retail Pharmacies
Online Pharmacies
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Alopecia Treatment (Hair Loss) Market Size Summary

The alopecia treatment market is experiencing significant growth driven by increasing awareness and the development of novel therapeutics. Alopecia, characterized by excessive hair loss due to medical conditions or dietary issues, is prevalent among various demographics, particularly middle-aged individuals facing hormonal imbalances and chronic diseases. The market is witnessing a surge in demand for treatments, with a notable portion of the female population seeking solutions due to the emotional and social impact of hair loss. The approval of new drugs and ongoing research are expected to further propel market expansion, with North America leading due to its advanced healthcare infrastructure and high treatment rates.

The market landscape is competitive, with key players like Sun Pharmaceuticals Industries Ltd., Aclaris Therapeutics Inc., and Concert Pharmaceuticals Inc. actively developing and marketing advanced products. The presence of high awareness levels and the frequency of conditions like Polycystic Ovary Syndrome (PCOS) contribute to the significant market share held by women. The United States, with its high prevalence of alopecia areata, serves as a major driver for the North American market. The strategic focus on innovative product development and regulatory approvals, such as orphan drug designations, underscores the dynamic nature of the alopecia treatment industry.

Explore More

Alopecia Treatment (Hair Loss) Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Alopecia

      2. 1.2.2 Increasing R&D Initiatives and New Product Launches and Approvals

    3. 1.3 Market Restraints

      1. 1.3.1 Patent Expiry of Many Blockbuster Drugs

      2. 1.3.2 Side Effects Associated with the Available Hair Loss Treatment Therapies

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Disease Type

      1. 2.1.1 Androgenic Alopecia

      2. 2.1.2 Alopecia Areata

      3. 2.1.3 Ciatricial Alopecia

      4. 2.1.4 Traction Alopecia

      5. 2.1.5 Alopecia Totalis

    2. 2.2 By Gender

      1. 2.2.1 Male

      2. 2.2.2 Female

    3. 2.3 By Route of Administration

      1. 2.3.1 Oral

      2. 2.3.2 Topical

      3. 2.3.3 Injectable

    4. 2.4 By Distribution Channel

      1. 2.4.1 Hospitals

      2. 2.4.2 Retail Pharmacies

      3. 2.4.3 Online Pharmacies

    5. 2.5 Geography

      1. 2.5.1 North America

        1. 2.5.1.1 United States

        2. 2.5.1.2 Canada

        3. 2.5.1.3 Mexico

      2. 2.5.2 Europe

        1. 2.5.2.1 Germany

        2. 2.5.2.2 United Kingdom

        3. 2.5.2.3 France

        4. 2.5.2.4 Italy

        5. 2.5.2.5 Spain

        6. 2.5.2.6 Rest of Europe

      3. 2.5.3 Asia-Pacific

        1. 2.5.3.1 China

        2. 2.5.3.2 Japan

        3. 2.5.3.3 India

        4. 2.5.3.4 Australia

        5. 2.5.3.5 South Korea

        6. 2.5.3.6 Rest of Asia-Pacific

      4. 2.5.4 Middle-East and Africa

        1. 2.5.4.1 GCC

        2. 2.5.4.2 South Africa

        3. 2.5.4.3 Rest of Middle-East and Africa

      5. 2.5.5 South America

        1. 2.5.5.1 Brazil

        2. 2.5.5.2 Argentina

        3. 2.5.5.3 Rest of South America

Alopecia Treatment (Hair Loss) Market Size FAQs

The Alopecia Treatment (Hair Loss) Market is projected to register a CAGR of 5.20% during the forecast period (2024-2029)

Sun Pharmaceuticals Industries Ltd., Johnson & Johnson, Concert Pharmaceuticals Inc., Cipla Inc. and Daiichi Sankyo are the major companies operating in the Alopecia Treatment (Hair Loss) Market.

Alopecia Treatment (Hair Loss) Market Report Snapshots

Alopecia Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)